Why is Nath Bio-Genes (India) Ltd ?
1
Weak Long Term Fundamental Strength with a -0.21% CAGR growth in Operating Profits over the last 5 years
- The company has been able to generate a Return on Equity (avg) of 6.31% signifying low profitability per unit of shareholders funds
2
Flat results in Sep 25
- INTEREST(Latest six months) At Rs 6.86 cr has Grown at 30.17%
- PAT(Q) At Rs 0.93 cr has Fallen at -16.1%
- CASH AND CASH EQUIVALENTS(HY) Lowest at Rs 0.74 cr
3
Falling Participation by Institutional Investors
- Institutional investors have decreased their stake by -1.58% over the previous quarter and collectively hold 1.08% of the company
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors
4
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -28.49% returns in the last 1 year, the stock has also underperformed BSE500 in each of the last 3 annual periods
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Other Agricultural Products)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Nath Bio-Genes for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Nath Bio-Genes
-28.49%
-0.77
37.14%
Sensex
4.83%
0.41
11.83%
Quality key factors
Factor
Value
Sales Growth (5y)
12.65%
EBIT Growth (5y)
-0.21%
EBIT to Interest (avg)
4.76
Debt to EBITDA (avg)
2.39
Net Debt to Equity (avg)
0.23
Sales to Capital Employed (avg)
0.47
Tax Ratio
6.57%
Dividend Payout Ratio
9.59%
Pledged Shares
13.78%
Institutional Holding
1.08%
ROCE (avg)
6.76%
ROE (avg)
6.31%
Valuation Key Factors 
Factor
Value
P/E Ratio
6
Industry P/E
14
Price to Book Value
0.40
EV to EBIT
8.72
EV to EBITDA
8.04
EV to Capital Employed
0.51
EV to Sales
1.02
PEG Ratio
1.83
Dividend Yield
1.40%
ROCE (Latest)
5.84%
ROE (Latest)
6.23%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Technical Movement
2What is working for the Company
NET SALES(Q)
At Rs 43.85 cr has Grown at 36.22%
-7What is not working for the Company
INTEREST(Latest six months)
At Rs 6.86 cr has Grown at 30.17%
PAT(Q)
At Rs 0.93 cr has Fallen at -16.1%
CASH AND CASH EQUIVALENTS(HY)
Lowest at Rs 0.74 cr
DEBT-EQUITY RATIO(HY)
Highest at 0.23 times
NON-OPERATING INCOME(Q)
is 56.76 % of Profit Before Tax (PBT
Loading Valuation Snapshot...
Here's what is working for Nath Bio-Genes
Net Sales - Quarterly
At Rs 43.85 cr has Grown at 36.22%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Here's what is not working for Nath Bio-Genes
Profit After Tax (PAT) - Quarterly
At Rs 0.93 cr has Fallen at -16.1%
Year on Year (YoY)MOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
Interest - Latest six months
At Rs 6.86 cr has Grown at 30.17%
over previous Half yearly periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (Rs cr)
Non Operating Income - Quarterly
is 56.76 % of Profit Before Tax (PBT)
MOJO Watch
The company's income from non business activities is high; which is not a sustainable business model
Non Operating Income to PBT
Cash and Cash Equivalents - Half Yearly
Lowest at Rs 0.74 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Debt-Equity Ratio - Half Yearly
Highest at 0.23 times
in the last five half yearly periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio






